Cargando…
Delivery of Personalized Care for Locally Advanced Rectal Cancer: Incorporating Pathological, Molecular Genetic, and Immunological Biomarkers Into the Multimodal Paradigm
Approximately one-third of all newly diagnosed colorectal cancer (CRC) is composed of rectal cancer, with the incidence rising in younger patients. The principal neoadjuvant treatments consist of neoadjuvant short-course radiotherapy and long-course chemoradiation. Locally advanced rectal cancer (LA...
Autores principales: | Ryan, Éanna J., Creavin, Ben, Sheahan, Kieran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456909/ https://www.ncbi.nlm.nih.gov/pubmed/32923389 http://dx.doi.org/10.3389/fonc.2020.01369 |
Ejemplares similares
-
Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer
por: Creavin, B, et al.
Publicado: (2017) -
An Analysis of Clinicopathological Outcomes and the Utility of Preoperative MRI for Patients Undergoing Resection of Mucinous and Non-Mucinous Colorectal Cancer Liver Metastases
por: Reynolds, Ian S., et al.
Publicado: (2022) -
Treatment paradigm and prognostic factor analyses of rectal squamous cell carcinoma
por: Liu, Rui, et al.
Publicado: (2023) -
Thymidylate Synthase as a Prognostic Biomarker for Locally Advanced Rectal Cancer after multimodal Treatment
por: Conradi, Lena-Christin, et al.
Publicado: (2011) -
Obesity may not be related to pathologic response in locally advanced rectal cancer following neoadjuvant chemoradiotherapy
por: Bao, Quoc Riccardo, et al.
Publicado: (2022)